-
China's Vincent Medical holdings invests $3mn in an Isreali firm
biospectrumasia
February 07, 2017
The deal is expected to help the Isreali firm capitalize on China's booming market for medical devices
-
STA Pharma Expands Changzhou Site
contractpharma
February 03, 2017
STA Pharmaceutical has expanded its new integrated R&D and commercial site in Changzhou, China. Adds R&D scientists and a new pilot plant.
-
The New King of Cancer Drugs, Can You Guess It?
en-cphi.cn
January 25, 2017
According to estimates, the new cancer cases in China reached 4.29 million cases in 2015, accounting for 20% of the world’s new cases, with 2.81 million death cases.
-
NuvOx Pharma and Jiangsu Nhwa Pharmaceutical Co., Ltd. sign Licensing Agreement for Hemorrhagic Shoc
firstwordpharma
January 25, 2017
NuvOx Pharma LLC and Jiangsu Nhwa Pharmaceutical Co., Ltd. (SZSE: 002262) have signed a licensing agreement for the exclusive development and sales of NVX-408 for China for treating hemorrhagic shock and perioperative blood loss.
-
US FDA grants orphan drug designation to Yisheng Biopharma’s PIKA rabies vaccine
pharmaasia
January 22, 2017
Currently under Phase II clinical development, the orphan drug designation is an important milestone for Yisheng Biopharma.
-
Valeant to sell Dendreon to China’s Sanpower for $819.9m
pharmaceutical-technology
January 13, 2017
Canada’s Valeant Pharmaceuticals’ affiliate has entered into an agreement to sell its equity interests in Dendreon Pharmaceuticals to China’s Sanpower Group for $819.9m.
-
MilliporeSigma Expands Biodevelopment Centers
contractpharma
January 11, 2017
New facilities in NA and China along with full single-use GMP facility in France to accelerate development of biologics